PhoenixMD Adds Seed Funding to Test Experimental Breast Cancer Drug

Phoenix Molecular Designs, a biotech developing kinase inhibitors to treat cancer, has brought in an undisclosed amount of financing?boosting its total seed funding raised to $12 million. The San Diego-based biotech says the proceeds will help fund the Phase 1/1b clinical trial of its lead candidate, PMD-026, an investigational cancer drug being developed to treat [?]